Summit Therapeutics' IPO

Summit Therapeutics raised a round of funding on March 05, 2015. Investors include Public.

Summit is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies. Summi…

Articles about Summit Therapeutics' IPO: